Quote:
Originally Posted by allinontheturn
RE: Supplement Companies
A friend of mine graduated college, hungry for a job with a BS in Chemistry. Took the first one offered at some tiny supplement company. They wanted him to sign off on the contents of their supplements. Seemed super shady to him, like if they ever ran afoul of the FDA for misrepresenting their product (which they were almost certain to in his opinion if they were ever investigated) he'd be the fall guy. Obv declined and quit. Shortly thereafter he got a job at 3M. They probably found some other sap tho.
/brool story
Yeah, lots of companies are super shady and essentially plan to do whatever until FDA notices (which in the current climate is unlikely), then just shut the door and slink away if that every happens. FDA is currently understaffed as it is, as the bulk of the recent legislation that was passed (the not at all subtly named FDASIA bill) was chiefly aimed at forcing health sciences companies to get their international suppliers in control. In turn, this means that FDA is necessarily required to have more of an international presence as well, which stretches the budgets even further.
The long and the short of it is that companies in the supplement space, even the dumb ones, probably have some appreciation that FDA operates on a risk based approach, and unless your product is killing someone FDA is unlikely to notice. Another trick that I personally believe is unlikely to continue to be allowed is representing all of these supplements as foods as opposed to a drug -- many products should technically be listed as such as the marketing materials either non-obliquely allude to or flat out state all of the conditions that the product is supposed to treat, i.e. they are marketing it to diagnose or treat a condition or disease (even with the bull**** disclaimer at the end of the commercials), i.e. it needs to have some clinical trials to support the claims. Unless you rustle some jimmies at FDA (a la Enzyte or Cheerios), this is unlikely to get noticed in the current climate.
My personal guess is that this market will continue to operate wild west style for at least another 10 years, until FDA realizes that they can raise a lot more money by making these facilities pay registration fees, which will also enable them to track and (ultimately) control them in a more efficient manner. If I'm still in consulting when the hammer drops, I imagine remediating these issues for companies that wish to stay in business would have the potential to be quite lucrative.